Filing Details

Accession Number:
0000885590-14-000054
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-24 16:37:21
Reporting Period:
2014-06-23
Filing Date:
2014-06-24
Accepted Time:
2014-06-24 16:37:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Valeant Pharmaceuticals International Inc. VRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1502213 Roswell Robert Chai-Onn 2150 St. Elzear Blvd. West
Laval A8 H7L 4A8
Evp, Gen. Couns. & Corp. Secy. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2014-06-23 10,203 $6.45 34,202 No 4 M Direct
Common Stock, No Par Values Disposition 2014-06-23 10,203 $121.70 23,999 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares, No Par Value Non-Qualified Stock Options (right to purchase) Disposition 2014-06-23 10,203 $0.00 10,203 $6.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-08-09 2014-08-09 No 4 M Direct
Footnotes
  1. This number represents options exercised and sold pursuant to a 10b5-1 trading plan covering these options, which were to expire on August 9, 2014.
  2. This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $121.51 and $121.95. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
  3. The options vested one-fourth per year over four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling fourth anniversary of the grant.